During development, progenitor cells with binary potential give rise to daughter cells that have distinct functions. Heritable epigenetic mechanisms then lock in gene expression programs that define lineage identity. Cd4 regulation in helper and cytotoxic T cells exemplifies this process, with enhancer-and silencer-regulated establishment of epigenetic memories for stable gene expression and repression, respectively. Using a genetic screen, we identified the DNA methylation machinery as essential for maintaining Cd4 silencing in the cytotoxic lineage. Further, we found a requirement for the proximal enhancer in mediating removal of Cd4 DNA methylation marks, allowing for stable expression in T helper cells. These findings suggest that stage-specific methylation and demethylation events in Cd4 regulate its heritable expression in response to the distinct signals that dictate lineage choice during T cell development.
INTRODUCTION
During metazoan development, a series of asymmetric cell divisions results in cells with a vast number of distinct phenotypes that are maintained throughout life. With rare exceptions, for example receptor gene segment rearrangements in B and T cells, the genome sequence remains unchanged as cells adopt new identities. Stable lineage commitment requires establishment of heritable patterns of gene expression or repression without alteration of DNA sequences, via epigenetic modifications. Despite a rapidly growing body of work that describes putative epigenetic regulation, physiological models in which epigenetic modulation can be functionally dissected and tested in fully differentiated cells are rare.
One of the rare examples in which heritable gene expression has been studied in depth is T cell lineage choice 1 . CD4 + helper and CD8 + cytotoxic T cells develop from common progenitors, based on the specificity of their T cell antigen receptors (TCRs) for peptidemajor histocompatibility complex (MHC) class II or class I molecules, respectively. The CD4 and CD8 co-receptors are critical to the development and function of these lineages, as they facilitate TCR binding to MHCII (CD4) and MHCI (CD8). CD4 and CD8 expression defines distinct stages of thymocyte development, during which ordered Tcr gene rearrangements occur and serve as developmental checkpoints. Early CD4 − CD8 − doublenegative (DN) progenitors transition through four distinct stages before up-regulating CD4 and CD8 to enter the CD4 + CD8 + double-positive (DP) stage of development. DP cells then test their randomly rearranged TCRs for MHCI and II specificity. MHCI-specific cells stably down regulate CD4 to enter into the cytotoxic lineage, while MHCII-specific cells lose CD8 expression and maintain CD4 expression during helper lineage differentiation.
The regulation of Cd4 expression during T cell development is an ideal setting for studying epigenetic regulation, as Cd4 exhibits heritable active and silenced states that can be maintained independently of the initiating genomic elements 1 . Elements required for this regulation have been identified in a series of in vivo genetic studies and in vitro T cell culture assays [2] [3] [4] [5] [6] . These include a 434 bp cis-acting silencer (S4), located in the first intron of the Cd4 locus, and a 430 bp cis-acting proximal enhancer (E4 P ), located 13 kb upstream of the transcriptional start site (TSS). S4 is essential for Cd4 repression at two different stages of T cell development. First, germline S4 deletion leads to ectopic CD4 expression in DN cells, indicating that it is required for reversible silencing before the DP stage of development. Second, S4 is required for silencing Cd4 in mature CD8 + cytotoxic cells, since germline S4 deletion results in ectopic CD4 expression in cytotoxic lineage cells. However, Cre-mediated conditional S4 deletion in mature CD8 + lineage cells following their thymic egress does not affect CD4 expression even after multiple cell divisions 5 . Similarly, in mature cytotoxic cells, Cre-mediated deletion of genes encoding members of the RUNX protein complex that binds S4 to initiate Cd4 silencing 3 fails to activate Cd4 gene expression (Egawa and Littman, unpublished) . This failure to activate Cd4 expression within cytotoxic cells is not due to the loss of Cd4 gene expression potential because germline S4 deletion results in robust CD4 expression in CD8 + cells and E4 P -Cd4 promoter reporter constructs exhibit strong activity upon delivery into mature CD8 + cells (J.R.H, D.R.L, unpublished).
Thus, S4 initiates Cd4 silencing in developing cytotoxic cells, but is completely dispensable for the maintenance of that silenced state.
The proximal enhancer initiates an analogous epigenetically active Cd4 expression state in CD4 + helper cells 7 . Germline E4 P deletion abrogated CD4 upregulation at the DN4 to DP transition during T cell development. However, a reduced number of MHCII-specific thymocytes were positively selected in Cd4 E4PΔ/E4PΔ mice, and these cells displayed moderate, but unstable, CD4 expression. Thus, in vitro or in vivo proliferation of Cd4 E4PΔ/E4PΔ helper cells resulted in the gradual loss of CD4. In contrast, Cre-mediated deletion of a loxP-flanked E4 P in mature helper cells did not affect CD4 expression, even after multiple cell divisions in vitro and in vivo. Thus, E4 P is required for the initiation of stable high expression of CD4, but is also dispensable for its maintenance.
The finding that established Cd4 silencing can be disassociated from the presence of S4 suggests the existence of a set of genes that epigenetically maintain silencing independently of S4. As T cells undergo multiple rounds of cell division after activation, these genes would need to both suppress CD4 re-expression (since CD8 + cells possess the capacity to express CD4) and actively pass the silenced state from parental to daughter cells independently of S4. To identify these putative trans-acting factors, we performed genetic screens using pooled retroviral shRNA libraries targeting the entire mouse genome. From these screens, DNA methyltransferase I (Dnmt1) was identified as a key factor in Cd4 silencing. Subsequent locus-wide methylation analyses revealed Cd4 hyper-methylation in DN, DP and CD8 + cells compared to CD4 + cells. We further found that in CD4 + and CD8 + T cells the Cd4 DNA methylation patterns are dependent on E4 P and S4, respectively. E4 Pdependent demethylation of the locus during the DP to CD4 + CD8 − thymocyte transition was achieved in the absence of cell division, consistent with the engagement of an active enzymatic process rather than passive demethylation. These results provide the first description of the epigenetic molecular machinery essential for the heritable regulation of Cd4 expression. Furthermore, they indicate that Cd4 gene regulation in mature T lymphocytes provides a unique opportunity to dissect the epigenetic mechanisms involved in establishing and maintaining gene expression or heritable silencing.
RESULTS

Unbiased screen for regulators of heritable Cd4 silencing
The factors that mediate bona fide epigenetic silencing of gene expression during T cell development remain poorly characterized. To identify trans-acting factors critical for maintaining Cd4 silencing in cytotoxic T cells (CD4 − CD8 + ), we performed an unbiased, genome-wide retroviral shRNA screen (Supplementary Fig. 1a ). We first activated spleen and lymph node CD8 + cells from Cd4 S4-L/+ Ubc-Cre-ER mice with anti-CD3 and anti-CD28 in the presence of OH-tamoxifen, to delete S4. We hypothesized that S4 deletion would allow for maximal sensitivity and ensure the identification of only true epigenetic modifiers by eliminating the possibility of S4 activity in mature CD8 + cells. After 18 h of activation, cells were transduced with pools of a retroviral shRNA library and expanded for 9 d with interleukin 2 (IL-2). On day 5, CD4 + cytotoxic cells were enriched using anti-CD4 magnetic beads. On day 10, a small percentage (~0.5%) of pooled shRNA virus-infected cells expressed CD4 in addition to CD8, but there was no expression in mock-infected cells (Fig.  1a) . These CD4 + CD8 + cells were sorted based on cell surface marker expression, and the shRNAs integrated into their genome were PCR-amplified, cloned and sequenced. Interestingly, 83% of the shRNAs isolated from infected CD4 + CD8 + cells were specific for Dnmt1 (two different shRNA clones targeting Dnmt1 were independently identified), indicating that DNA methylation may be important for the maintenance of Cd4 silencing in fully differentiated cytotoxic T cells.
DNA methylation machinery maintains Cd4 silencing
To validate the results of our screen and to determine if DNA methylation enzymes are important for Cd4 silencing, we interfered with DNA methyltransferase activity by using shRNA knockdown and mice with targeted mutations in Dnmt genes. Cytotoxic T cells activated by CD3 and CD28 crosslinking and transduced with the Dnmt1 shRNAs identified in the screen exhibited increased surface CD4 expression compared to cells transduced with a control vector ( Supplementary Fig. 1b and data not shown). To rule out off-target shRNA effects, we also tested CD4 expression after genetic manipulation of DNA methyltransferase activity. Since Dnmt1 deletion leads to lymphocyte death after a limited number of cell divisions 8 , we analyzed the maintenance of Cd4 silencing using a hypomorphic mutation in the Dnmt1 locus 9 , Dnmt1 Chip , in which Dnmt1 expression is reduced to ~10% of wild-type. In mice homozygous for the hypomorphic mutation (Dnmt1 Chip/Chip ) or hemizygous for the mutation (Dnmt1 L/Chip Cd4-Cre ), 1-2 % of cytotoxic T cells upregulated CD4 expression following in vitro activation and expansion (Fig. 1b and data not shown) . Further reduction of Dnmt1 expression in these cells using Dnmt1 shRNA led to CD4 expression on ~10% of the cytotoxic cells (Fig. 1b) . If this result reflects a requirement for Dnmt1-directed maintenance methylation in Cd4 silencing, then CD4 expression may be expected to increase progressively with successive cell divisions due to passive DNA demethylation. To examine this, we transduced CD8 + T cells with control or Dnmt1 shRNAs, then labeled the cells with the fluorescent dye e670 and quantified CD4 expression through multiple rounds of cell division, as assessed by dye-dilution. Similarly to CFSE, e670 binds covalently to cellular proteins during staining and is distributed evenly between daughter cells upon cell division. Consistent with a role for Dnmt1-mediated maintenance methylation in Cd4 silencing, we found increased CD4 expression with increased numbers of cell divisions ( Supplementary Fig. 1c ).
To better assess the role of the DNA maintenance methylation machinery in Cd4 silencing, we monitored CD4 expression in long-term, in vivo cell proliferation assays. First, we adoptively transferred Dnmt1 hypomorphic cytotoxic T cells into T cell-deficient lymphopenic hosts. After 2-3 weeks, 10-20% of transferred cells expressed CD4 in addition to CD8 (data not shown). Since Dnmt1 deficiency can compromise proliferation, we attempted to reduce methylation content further in Dnmt1 hypomorphic mice by removing alternative methylation machinery, namely Dnmt3a and Dnmt3b. The de novo methyltransferases Dnmt3a and Dnmt3b have also been implicated in DNA maintenance methylation 10, 11 and their deletion does not significantly affect T cell proliferation (not shown). Compared to Dnmt3a deletion on a Dnmt1 hypomorphic background, Dnmt3b deletion had a relatively weak effect on Cd4 gene expression in cytotoxic T cells (data not shown). Intriguingly, eliminating Dnmt3a in Dnmt1 hypomorphic mice resulted in robust CD4 expression (>75%) after in vivo expansion (Fig. 1c) . These data clearly demonstrate that DNA methylation machinery is critical for ensuring stable Cd4 silencing in cytotoxic T cells.
S4-dependent, cytotoxic lineage DNA hyper-methylation
The requirement for DNA methyltransferases in Cd4 silencing implied that there would be differences in 5′-methyl-cytosine (5mC) modifications of CpG dinucleotides within the locus in helper and cytotoxic T cells, and that the differences could be dependent on S4. To test this hypothesis, we isolated genomic DNA from peripheral wild-type CD4 + helper and CD8 + cytotoxic, and Cd4 S4Δ/S4Δ CD4 + CD8 + cytotoxic T cells, and enriched for the Cd4 locus flanked on each side by ~75 kb, by CATCH-Seq; this method uses BAC clone templates to generate probes for target capture hybridization-based locus enrichment, followed by bisulfite sequencing 12 . CATCH-Seq resulted in >30x sequencing coverage for 97.6% of target CpGs per sample, on average, and was highly reproducible between biological replicates ( Supplementary Fig. 2 ). We identified a strongly differentially methylated region (DMR) from ~ +3.2 kb to −0.7 kb relative to the Cd4 TSS ( To ascertain if the hyper-methylation pattern observed in CD8 + T cells was stable, we also examined DNA methylation after multiple cell divisions. Wild-type CD4 + , wild-type CD8 + and Cd4 S4Δ/S4Δ CD4 + CD8 + cells that had undergone >5 divisions following in vitro stimulation, as assessed by CFSE dilution, maintained DNA methylation patterns similar to those of their ex vivo precursors ( Fig. 2c and Supplementary Fig. 4d ). These methylation patterns were also conserved after 20 days and >10 cell divisions of expansion in lymphopenic hosts ( Supplementary Fig. 4e ). Thus, consistent with a direct role for DNA methylation in regulating the heritable silencing of Cd4, S4 dictates Cd4 locus hypermethylation in cytotoxic T cells, which in turn is stable through multiple cell divisions.
Cd4 locus DNA is hyper-methylated in T cell progenitors
The finding of heritable Cd4 DNA hyper-methylation in CD8 + T cells and hypo-methylation in CD4 + T cells suggested that the locus undergoes selective de novo methylation as DP cells differentiate towards the cytotoxic lineage. To determine if this was indeed the case, we analyzed DNA methylation by CATCH-Seq, as well as amplicon sequencing.
Unexpectedly, we found that the Cd4 locus was already hyper-methylated both at the DN3 and DP stages (Fig. 3a, Supplementary Fig. 4f-g ). Most of the methylated CpGs were retained in CD8 single-positive thymocytes (CD8SP; the "SP" suffix will be used to denote maturing helper and cytotoxic cells from the thymus), while a substantial number converted to the unmethylated state in CD4SP cells (Fig. 3a) . Germline S4 deletion did not affect DNA methylation in DP cells (Fig. 3b, Supplementary Fig. 4h ), suggesting that while silencermediated activity is required to sustain DNA methylation as cells transition from DP precursors to the CD8 lineage, it is not required to maintain locus methylation in DP cells. Overall these data indicate that the Cd4 locus becomes hyper-methylated early in T cell development, and is then selectively demethylated during specification of the CD4 + Thelper lineage.
DMR methylation does not grossly alter chromatin structure
We next considered how hyper-methylation of the Cd4 locus could impact silencing. As DNA methylation can regulate nucleosome stability and positioning in some contexts 14, 15 , we evaluated the possibility that Cd4 locus DNA methylation could impact nucleosomes and, hence, chromatin compaction. Thus, we used micrococcal nuclease digestion and CATCH-seq to identify nucleosomes from diverse samples, including DN3, DP, CD4 + , CD8 + , Cd4 E4PΔ/E4PΔ DP, Cd4 E4PΔ/E4PΔ CD4 + , Cd4 S4Δ/S4Δ DP, and Cd4 S4Δ/S4Δ CD8 + . We found that the loss of nucleosomes at ~ +3.5 kb relative to the TSS, immediately downstream of the TSS-proximal DMR, correlated strongly with CD4 expression (Supplementary Fig. 5 ). However, DNA methylation content did not correlate well with differential nucleosome positioning, indicating that this is unlikely to be a critical function of Cd4 locus 5mC marks in facilitating silencing.
Cd4 hypo-methylation correlates with stable CD4 expression
Cd4 hypo-methylation in helper lineage cells led us to hypothesize that the removal of 5mC marks is critical for heritable, high-level CD4 expression. To determine if this may be the case, we assessed if 5mC content was dependent on the Cd4 proximal enhancer. E4 Pdeficient CD4 + helper T cells exhibited unstable CD4 expression upon cell division 7 . Interestingly, in naive Cd4 E4PΔ/E4PΔ CD4 + cells there was Cd4 TSS-proximal DMR hypermethylation, with 5mC content approaching that observed in mature wild-type CD8 + cells (Fig. 4a) and correlating with unstable CD4 expression. Further, when we stimulated naïve Cd4 E4PΔ/E4PΔ CD4 + cells to proliferate in vitro and analyzed Cd4 methylation patterns locus-wide in CD4 + and CD4 − cells after >5 cell divisions, those cells that lost CD4 expression exhibited more TSS-proximal DMR methylation (Fig. 4b) . Thus, in helper T cells, Cd4 locus hypo-methylation correlated with more stable maintenance of CD4 expression (maintaining CD4 expression after > 5 cell divisions), while hyper-methylation correlated with loss of CD4 expression. In Cd4 E4PΔ/E4PΔ thymic DP cells, which lack CD4 expression 7 , the Cd4 methylation pattern was most similar to that in wild-type DN3 cells, with hyper-methylation ±1 kb from the location of E4 P (Supplementary Fig. 6 ). Taken together, these results suggest that E4 P contributes to stable CD4 expression in the helper lineage by facilitating heritable Cd4 locus de-methylation.
Reduced DNMT1 rescues E4 P -KO helper cell CD4 expression
To determine if there may be a causal link between Cd4 locus hypo-methylation and heritable CD4 expression, we interfered with DNMT1 expression in E4 P -deficient helper cells. We sorted naïve CD4 + cells from Dnmt1 L/L Cd4-Cre + , Dnmt1 L/Chip Cd4-Cre + and Dnmt1 L/L Cd4-Cre − mice, all on a Cd4 E4PΔ/E4PΔ background, and analyzed CD4 expression at various time points after activation.
We measured CD4 protein expression, as it correlates with mRNA expression in Cd4 E4PΔ/E4PΔ T cells 7 . At 72 h, 76.2% of Dnmt1-sufficient cells maintained CD4 expression (Fig. 5a ). In contrast, Dnmt1-knockout and Dnmt1-hypomorphic cells exhibited higher proportions of CD4 + cells (94.9% and 87.6%, respectively; Fig. 5a ). CD4 + Dnmt1-hypomorphic Cd4 E4PΔ/E4PΔ cells also exhibited ~30% higher CD4 mean fluorescence intensity (MFI) compared to Dnmt1 +/+ Cd4 E4PΔ/E4PΔ CD4 + cells at 72h, indicating higher CD4 expression in the cells that remained CD4 + (Fig. 5b) . The increased proportion of CD4 + cells (20-25% higher) and increased MFI (40-47% higher) in Dnmt1 hypomorphic versus Dnmt1-sufficient cells was also observed at 96 h and 120 h ( Supplementary Fig. 7a-b) . Importantly, these results were not due to differences in proliferative capacity because the fraction of CD4 + cells was consistently higher in Dnmt1-deficient cells compared to wild-type across each cell generation as measured by CFSE dilution (Fig. 5c, Supplementary  Fig. 7c ). Transduction of Cd4 E4PΔ/E4PΔ CD4 + T cells with retroviruses encoding Dnmt1 shRNAs led to a similar result ( Supplementary Fig. 7d-e) . The results are thus consistent with E4 P -dependent demethylation of the Cd4 TSS-proximal DMR being critical for establishing heritable high CD4 expression.
DMR demethylation occurs during helper lineage commitment
We next asked when DNA demethylation occurs within helper lineage cells. We examined Cd4 TSS-proximal DMR methylation by amplicon bisulfite sequencing at different stages after positive selection and during helper lineage differentiation using a Zbtb7b GFP reporter mouse 16 . Zbtb7b (which encodes ThPOK) is required for CD4-lineage commitment, and GFP is expressed from the Zbtb7b GFP allele specifically in MHCII-selected cells [16] [17] [18] . We sorted positively selected CD69 + HSA + CD4 + CD8 lo cells prior to lineage commitment (GFP − ; includes both MHCI-and MHCII-specific cells), early in helper lineage commitment (GFP mid ) and late in commitment (GFP hi ), as well as mature CD4SP cells (CD4 + CD8 − TCRβ hi HSA lo CD69 lo GFP hi ) ( Supplementary Fig. 8a-c) . Using a representative TSS-proximal DMR amplicon (Fig. 6a) , we found almost complete methylation in DP (Supplementary fig. 4g ), CD4 + CD8 lo GFP − and GFP mid cells (Fig. 6b) . DNA methylation began to decrease in GFP hi CD4 + CD8 lo cells, late in commitment, and was nearly absent in CD4SP cells, consistent with our earlier results (Fig. 6b) . Thus, Cd4 locus differential methylation is initiated by the removal of DNA methylation marks late in helper lineage commitment, around the time of maximal Zbtb7b induction, and is completed at the mature CD4SP stage.
Zbtb7b is partially dispensable for Cd4 demethylation
Our observation that DNA demethylation in the helper lineage occurs after Zbtb7b is maximally induced suggested that Zbtb7b may play a role in the removal of these methylation marks. To test this hypothesis, we first assessed DNA methylation by amplicon sequencing in MHCII-selected, Zbtb7b GFP/GFP CD4 + CD8 lo and CD8SP T cell subsets. In Zbtb7b GFP/GFP mice, MHCII selected cells continue to express the GFP reporter allele, but are redirected into the cytotoxic lineage due to Zbtb7b deficiency 16 . We found that, despite the absence of Zbtb7b, MHCII-selected cells began to lose DNA methylation at the CD4 + CD8 lo GFP hi stage (Fig. 6c) . While Zbtb7b GFP/GFP CD8SP GFP + cells exhibited higher methylation than Zbtb7b GFP/+ GFP + CD4SP cells, they were hypo-methylated compared to wild-type CD8SP cells (Fig. 6c,d) . Thus Zbtb7b appears to be at least partially dispensable for intronic DMR demethylation in MHCII-selected cells. We confirmed this result by bisulfite CATCH-Seq across the Cd4 locus in mature peripheral MHCI (GFP − )-and MHCII (GFP + )-selected Zbtb7b GFP/GFP CD8 + cells (Fig. 6e) . GFP + cells exhibited TSS-proximal DMR hypo-methylation similar to wild-type CD4 + cells, while MHCI-selected GFP − cells exhibited hyper-methylation similar to wild-type CD8 + cells (Fig. 6e) . Interestingly, when induced to proliferate in vitro, GFP + Zbtb7b GFP/GFP CD8 + cells maintained high CD8 expression, but also initiated CD4 expression (Fig. 6f) 
Cell division-independent Cd4 locus demethylation
The removal of DNA methylation marks in the Cd4 locus late in lineage commitment raises the question of whether demethylation is passive, by way of cell division, or active, through biochemical removal of 5mC marks. Among the 21 differentially methylated CpGs of the TSS-proximal DMR, the median DP:CD4SP CpG methylation ratio is 4.3 (mean: 27.6). Thus, passive demethylation would require an average of at least 2 cell divisions during helper lineage differentiation to effect passive demethylation, and over 9 divisions to explain the demethylation observed at some residues. Previous reports have suggested that there is no cell division between the DP and CD4SP stages of development 19 , or that a minority (<20%) of CD4SP cells may divide after HSA down-regulation and within hours of thymic emigration 20, 21 . Moreover, our amplicon analysis of CD4 + CD8 lo MHCII-selected cells revealed stochastic loss of DNA methylation consistent with biochemical removal or passive demethylation with some remethylation (for example, seemingly random loss of methylation at only a subset of CpGs on a given allele), rather than the mixture of all methylated and all demethylated alleles that would be indicative of purely passive demethylation resulting from cell division without maintenance methylation. To further rule out the possibility of proliferation-mediated passive demethylation, we used a CFSE labeling and thymic injection technique to determine if cells divide during differentiation into the helper lineage. We sorted CD69 − DP cells from CD45.2 B2m Δ/Δ H2-Ab1 Δ/Δ OT-II-TCR-transgenic mice, mixed these with CD45.1 CD69 − DP cells, stained with CFSE and injected into the thymi of CD45.1 mice that expressed MHCI and MHCII. At four days after injection, thymi were isolated and CFSE intensity and lineage differentiation were assessed by flow cytometry ( Supplementary Fig. 8d-f) . Among both CD45.1 + and CD45.2 + injected cells, we could identify pre-selected cells (CD69 − DP), positively selected (CD4 + CD8 lo CD69 + TCRb med/hi ) and mature CD4SP cells (CD4 + CD8 − CD69 lo TCRb hi ). All three groups expressed similarly high CFSE labeling, indicating no difference in cell divisions after injection. Importantly, the lack of cell division was not due to loss of viability, as these cells were able to differentiate, modulating the expression of CD69, TCRβ, CD4 and CD8. Thus, without evidence of significant proliferation following positive selection, we conclude that DNA methylation is removed from the Cd4 locus during helper lineage commitment via an active biochemical process, independent of cell division.
Ten Eleven Translocation (TET) enzyme-mediated oxidation of 5mC to 5-hydroxymethylcytosine (5hmC) has recently been shown to contribute to active DNA demethylation pathways 22 . To determine if TET-mediated hydroxymethylation of 5mCs in the Cd4 locus could contribute to locus demethylation, we examined 5hmC content by T4-phage β-glucosyltransferase (T4-βGT) -mediated restriction enzyme protection-qPCR. We isolated genomic DNA from DP, CD4 + and MHCII-selected CD4 + CD8 lo cells (CD69 + HSA + CD4 + CD8 lo GFP + cells from Zbtb7b GFP/+ mice) and incubated the DNA with or without T4-βGT in the presence of glucose-UTP, before digestion with a restriction enzyme sensitive to modified 5hmC, MspI. T4-βGT transfers glucose-UTP specifically to 5hmC residues, blocking MspI digestion of CCGG motifs. In DP and CD4 + cells, we found very little T4-βGT protection of a differentially methylated CCGG motif at +190 bp relative to the Cd4 TSS (Fig. 7a, <20% ). However, we found significantly greater T4-βGT-mediated protection of the same motif in MHCII-selected CD4 + CD8 lo cells (~40%), consistent with TET-dependent 5hmC-mediated demethylation in differentiating helper lineage T cells. Importantly, this CpG lies near the middle of the TSS-proximal DMR, and its methylation status during T cell differentiation is representative of the other dynamically and differentially methylated CpGs in the TSS-proximal DMR. To confirm and expand on these results, we performed oxidative-bisulfite amplicon sequencing on a group of three representative CpGs located at +1407 to +1487 relative to the TSS. While both 5mC and 5hmC are read as cytosine after bisulfite treatment, 5hmC can be oxidized by KRuO4 to 5-formylcytosine, which is then read as thymine after bisulfite treatment 23 . Thus, bisulfite treatment, with or without oxidation, can be used to differentiate 5mC from 5hmC modifications.
In DP cells, we found that all three CpGs were highly methylated (>90% 5mC/5hmC by bisulfite treatment alone), with low amounts of 5hmC at two CpGs (<20% 5hmC at CpGs 1 and 2) and moderate amounts at a third (< 50% 5hmC at CpG 3) (Fig. 7b) . While overall methylation content remained similar, we observed decreased 5mC and increased 5hmC in post-selection CD4 + CD8 lo cells compared to DP cells (Fig. 7b,c) , in keeping with our previous results. It should be noted that CD4 + CD8 lo cells are predominantly (> 2:1) MHCII selected 16 . Taken together, these results are consistent with our finding that demethylation of the TSS-proximal DMR after selection on MHCII does not require cell division, and suggest that it may be achieved enzymatically via a hydroxymethylated intermediate.
DISCUSSION
The molecular mechanism for heritable epigenetic Cd4 silencing in cytotoxic T cells has remained elusive despite characterization of the key cis-and transacting factors required to establish the silenced state. We have shown here that DNA methyltransferases are required to maintain silencing in CD8-lineage T cells, and linked this requirement to Cd4 locus methylation. Conversely, our data indicate that stable CD4 expression in CD4-lineage T cells is regulated by proximal enhancer-dependent Cd4 locus DNA demethylation. Surprisingly, the Cd4 TSS-proximal lineage DMR was methylated early in development, in both DN and DP thymocytes, indicating that a critical function of the silencer is to antagonize demethylation in CD8-lineage cells. Finally, demethylation of the DMR in CD4-lineage thymocytes appears to involve an active enzymatic process that is likely mediated by TET-dependent oxidation of methylcytosines. Thus, heritable Cd4 silencing versus expression is directed by a DNA demethylation switch under the control of the silencer and proximal enhancer.
Our results indicate that Cd4 locus methylation is necessary, but not sufficient, for stable Cd4 silencing. Indeed, DP cells express similar amounts of CD4 to helper T cells, but exhibit Cd4 locus hyper-methylation comparable to cytotoxic lineage cells. This uncoupling of TSS-proximal DMR methylation from transcription implies that Cd4 locus methylation/ demethylation is critical for establishing heritable Cd4 expression states rather than transcriptional activity. Still, the question remains: how do DP cells express CD4 in the face of TSS-proximal methylation? It could be due to developmental stage specific transacting factor expression. For example, Runx1 is down-regulated at the DN4 to DP transition 3, 24 , which could contribute to reduced S4 activity, allowing CD4 expression in spite of DNA hyper-methylation. Alternatively, or in conjunction with low Runx levels, DP cells may express yet to be identified stage-specific Cd4 activators. Further, it should be noted that there are a handful of Cd4 locus CpGs that are hypo-methylated in DP cells and CD4 + cells relative to CD8 + and DN cells; hypo-methylation of these residues in DP cells could contribute to CD4 expression in DP cells, while their de novo methylation in CD8 + cells could contribute to silencing. Finally, it is possible that CD8 lineage cells express lineage specific factors, possibly including Runx3, that collaborate with 5mC modifications to impose a silenced state.
Our data strongly suggest that stable helper lineage CD4 expression depends on an E4 Pdirected active DNA demethylation process in MHCII-selected thymocytes: first, E4 P is required for CD4-lineage Cd4 locus hypo-methylation; second, there is little to no cell division between the DP (hyper-methylated) and CD4SP (hypo-methylated) stages of development; third, we found 5hmC in MHCII-selected CD4 + CD8 lo cells at TSS-proximal DMR CpGs, which are demethylated during the DP to CD4SP transition, consistent with 5mC oxidation by TET enzymes. E4 P becomes dispensable in mature cells 7 , in which a "maturation enhancer", putatively localized adjacent to the silencer element in intron 1 ( 13 and PDI and DRL, unpublished), and within the TSS-proximal DMR, programs CD4 expression. Thus, it seems likely that the critical function of E4 P is to effect TSS-proximal demethylation across the promoter and sequences flanking intronic regulatory elements, which then allows the maturation enhancer to direct CD4 expression. It is worth noting, however, that Tet enzymes can further oxidize 5hmC to 5-formylcytosine (5fC) and 5-carboxycytosine (5caC) [25] [26] [27] , which are read as "unmodified" cytosines by bisulfite sequencing 23 . Thus we cannot rule out that the unmethylated CpGs identified in differentiating CD4 lineage cells represent 5fC or 5caC. Further studies will be required to determine how demethylation and/or oxidation of cytosine residues are critical for establishing heritable CD4 expression.
Central questions raised by our study are how E4 P directs demethylation in the CD4-lineage and how S4 maintains the minimally altered methylation pattern following the DP stage to CD8-lineage transition. While it is possible that Tet enzymes are recruited to E4 P upon TCR signaling, we also noticed that the TSS-proximal DMR contains some 5hmC modifications in wild-type DP cells and that E4 P is responsible for DP cell hypo-methylation of E4 P proximal CpGs. Thus it is tempting to hypothesize that E4 P recruits Tet enzymes in DP cells or earlier, to poise the locus for demethylation before positive selection and lineage commitment. Could S4 then inhibit the recruitment or activity of TET enzymes in the Cd4 locus in MHCI-selected cells? Runx3 expression is induced in MHCI-selected cells during the DP to CD8SP transition 28 , and the RUNX fusion proteins found in acute myeloid leukemia have been shown to recruit DNMT proteins to target genes, presumably through an indirect mechanism 29, 30 . Thus it is possible that Runx3 could recruit DNMTs to the Cd4 locus to ensure maintenance methylation. It will be important to determine if and how TET enzymes are targeted to the Cd4 locus in an E4 P -dependent manner and whether DNMT enzymes are recruited in an S4-and Runx3-dependent manner during the CD4 + CD8 lo to CD8 + SP transition.
Cd4 is arguably the best-characterized locus in vertebrates for the study of heritability, but the mechanisms by which its heritable states are controlled have remained elusive for years. The findings that the DNA methylation machinery is critical for the establishment and maintenance of silencing and that de-methylation is critical for heritable expression represent a significant advance and offer new opportunities to dissect the signaling pathways involved in thymocyte lineage choice. These results also establish Cd4 as a unique model to understand how DNA demethylation is effected and regulated. Further investigation of how the Cd4 locus is controlled via DNA methylation can thus provide important insights into how fully differentiated somatic cells achieve heritable states of gene expression.
METHODS
Mice
Dnmt1 L 31 and Dnmt1 Chip 9 mice were a kind gift from R. Jaenisch. Dnmt3a L 32 and Dnmt3b L 33 were from the Mutant Mouse Regional Resource Center (MMRRC). Cd4 E4PΔ 7 , Cd4 S4Δ , Cd4 S4-L 5 , and Zbtb7b GFP 16 were previously described. WT C57BL/6, Cd4-Cre 8 , Ubc-Cre ER-T2 34 , H2-AbI 35 , B2m 36 , Rag2, Ly5.1, Ly5.2 and Tg(TcraTcrb)425Cbn (OT-II TCR tg) mice were purchased from the Jackson Laboratory. All mice were maintained under specific pathogen-free conditions in the Skirball Institute Animal Facility. All experiments were performed in accordance with the protocol approved by the IACUC at the NYU School of Medicine.
shRNA screen
The mouse shRNA mir library 37 was used to generate ten retroviral pools, each comprising ~6000 shRNA clones 38 . CD62L + CD25 − CD8 + cells, isolated from spleens and lymph nodes of Cd4 S4-L/+ ; Ubc-Cre ERT2 mice, were cultured with anti-CD3 (0.25 μg/ml) and anti-CD28 (1 μg/ml) in the presence of OH-tamoxifen (400 nM) for 16 h before transduced with the retroviral pools. After 7 days culture in the presence of IL-2 (100 U/ml), CD4-positive cells were enriched by CD4 + MACS column. After 3 days, double-positive cells (CD4 + CD8 + ) were sorted and their genomic DNA isolated. To identify the candidate shRNAs, the shRNA region of the transduced virus was PCR amplified, cloned and sequenced. Individual shRNAs were either obtained from the Open Biosystems library or synthesized. Two shRNA clones targeting Dnmt1 were identified (5′-GTACACCTTTCATGATGTGAAA-3′ and 5′-TCCCGAAGATCAACTCACCAAA-3′).
Flow cytometry and sorting
Monoclonal antibodies were purchased from eBioscience or BD Bioscience. Clones used were: anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRβ (H57-597), anti-HSA (M1/69), anti-CD69 (H1.2F3), anti-CD44 (IM7), anti-CD62L (MEL-14), anti-CD45.1 (A20), anti-CD45.2 (104), CD25 (PC61) and anti-Thy1.2 (53-2.1). CFSE and e670 were obtained from Molecular Probes. After staining with antibodies and DAPI (Molecular Probes), cells were analyzed with an LSRII flow cytometer (BD Biosciences) or sorted with an Aria II (BD Biosciences). Post sort sample purity was >98%. In some cases, anti-CD4, anti-PE, anti-B220 magnetic beads (Miltenyi) were used for enrichment and depletion on the Auto-MACS platform (Miltenyi) before sorting. Flow cytometry data was analyzed using Flowjo software (Tree Star).
Cell culture
Tissue culture plates were incubated overnight with polyclonal goat anti-hamster IgG (MP biomedicals), washed 3x with PBS, and purified CD4 + CD8 − CD25 − CD62L + CD44 lo or naïve CD4 − CD8 + CD25 − CD62L + CD44 lo T cells were added, along with anti-CD3 (145-2C11, 0.25 μg/ml) and anti-CD28 (37.5.1, 1 μg/ml) antibodies. At day 3, cultures were supplemented with 100 U/ml recombinant IL-2 (Peprotech). For Dnmt1 knockdown, the Dnmt1 shRNA sequences were inserted into a miR-30-based hairpin of the pMSCV-LMP vector (Open Biosystems) according to the manufacturer's instruction. Retroviruses were packaged in PlatE cells 39 by transient transfection using TransIT 293 (Mirus Bio). Cells were transduced by spin infection at 1,200 × g at 30 °C for 90 min in the presence of 10 μg/ml polybrene (Sigma).
Methylation analysis
Genomic DNA was isolated using Purelink genomic DNA isolation kits (Invitrogen). For locus-wide bisulfite sequencing, CATCH-seq was performed as described 12 , using BAC clone RP24-330J12 (BACPAC Resource Center, CHORI). For amplicon sequencing, bisulfite conversion was performed using the EpiTect Bisulfite Kit (Qiagen). Amplicons were prepared using Hot Start Ex-Taq Polymerase (TaKaRa) and the following primers: TSS-F: 5′-GGGGTATTTATTGTTTTGAGTAT-3′, TSS-R: 5′-TTTAATTTTTCAACTTCCCCAAC-3′, +1600-F: 5′-GGTTATTTGGAGTTTTTTTTTAG-3′, +1600-R: 5′-CTTCAATTCATAAACTTATTCCC-3′, and TA cloned using the Qiagen PCR cloning kit.
Bisulfite analysis of Sanger sequenced clones was performed using QUMA 40 . Oxidative bisulfite treatment was performed as previously described 41 and amplicons were analyzed as above using the following primers: +1400-F: 5′-AAGTGTTTAAAATGTGTTAATTATTG-3′, +1400-R: 5′-TTAAAAACAAAACTAAAAAAACCC-3′. T4-βGT-mediated 5mC-and 5hmC-sensitive restriction enzyme digest was performed using the EpiMARK 5-hmC and 5mC analysis kit according to the manufacturer's instructions (New England Biolabs). Quantitative PCR was performed using HotStart-IT SYBR Green qPCR Master Mix (Affymetrix-USB) and a LightCycler 480 (Roche). Percent digestion was calculated using ΔΔCt.
Nucleosome analysis
Nucleosomes were prepared as previously described 42 . Briefly, 1.1 × 10 7 cells were lysed in digestion buffer (50 mM Tris-HCl, pH 7.5, 1 mM CaCl 2 , 0.2% Triton X-100) supplemented with protease and deacetylase inhibitors. Nuclei were then treated with 12 U Micrococcal Nuclease (Worthington Biochemical) in 135 μl digestion buffer for 5 min at 37 °C to produce >90% mono-nucleosomes. The reaction was quenched by adding EDTA to 25 mM EDTA and EGTA to 10 mM. Samples were spun for 5 min at 2500g and supernatants with solubilized mononucleosomes were reserved (digestion supernatants). Pelleted nuclei were then lysed twice for 1 h on ice in lysis buffer (150 μl of 1 mM Tris-HCl, pH 7.5, 0.25 mM EDTA; supplemented with Protease and deacetylase inhibitors), following gentle sonication. After removing nuclear debris by centrifugation (5 min at 11,000g), nuclear lysis supernatants were pooled with digestion supernatants. Mononucleosome fragments were then subjected to CATCH-seq.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. (a) Genomic DNA from DP, naïve CD4 + and MHCII-selected CD4 + CD8 lo cells (CD69 + HSA + CD4 + CD8 lo GFP + cells from Zbtb7b GFP/+ mice) was incubated with Uridine Diphosphate Glucose (UDG), with or without β-glucosyltransferase (βGT), before digestion with MspI. T4-βGT transfers UDG specifically to 5hmC residues, blocking MspI digestion of CCGG motifs. MspI digestion (at Chr6:124838036; +191bp relative to the Cd4 TSS) was assessed by qPCR comparison to undigested DNA. As a loading control, values were normalized to an adjacent amplicon without a MspI site. The mean and SD of 3 (CD4 + ) or 4 (DP and CD4 + CD8 lo ) independent biological samples analyzed in two independent experiments are shown; P values (unpaired student's t-test) below 0.05 (*) and 0.01 (**) are noted. (b-c) Genomic DNA from DP and CD4 + CD8 lo cells was subjected to bisulfite amplicon sequencing (BS) or KRuO4-oxidation followed by bisulfite amplicon sequencing (OxBS). (b) Pie charts represent the mean percentage of the indicated cytosine modifications at three CpGs located from +1407 to +1487 relative to the Cd4 TSS (CpG 1 = Chr #6:124836820; CpG 2 = Chr #6:124836779; CpG 3 = Chr #6:124836740), in DP (n=2) and CD4 + CD8 lo cells (n=2); Data were combined from 2 independent experiments: 4-13 amplicons (BS) or 11-17 amplicons (OxBS) were analyzed for each sample. (c) The mean and SD of the indicated modifications at the 3 CpGs in (b) were graphed for DP and CD4 + CD8 lo cells (circles and triangles represent the measurements for individual DP and CD4 + CD8 lo CpGs, respectively). 5hmC levels were calculated by subtracting the percentage
